Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Utility of an improved model of amyloid-beta (Aß1?42) toxicity in Caenorhabditis elegans for drug screening for Alzheimer's disease.

Utility of an improved model of amyloid-beta (Aß1?42) toxicity in Caenorhabditis elegans for drug screening for Alzheimer's disease. Mol Neurodegener. 2012 Nov 21; 7:57.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.